Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.
Genmab A/S is a publicly-traded international biotechnology company that creates and develops fully human monoclonal antibody-based products for the treatment of life-threatening and debilitating diseases. Genmab has numerous products in development to treat cancer and we are continuing to build a broad portfolio of new therapeutic products.
